Old Web
English
Sign In
Acemap
>
authorDetail
>
Ruiyun Jiang
Ruiyun Jiang
Celgene
Medicine
Bortezomib
Multiple myeloma
Internal medicine
Oncology
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Line of therapy (LOT) definition impacts second-line (2L) survival duration in a metastatic pancreatic cancer (mPCa) electronic health record database.
2019
Journal of Clinical Oncology
Susan Meredith Fish
E. Dawn Flick
Arlene S. Swern
Ruiyun Jiang
Gilbert Jirau-Lucca
Michael Ondovik
Jian Hua Huang
Chrystal Ursula Louis
Show All
Source
Cite
Save
Citations (0)
Pomalidomide + Bortezomib + Dexamethasone After One Prior Line of Therapy in Bortezomib-Pretreated Multiple Myeloma: Subanalysis of OPTIMISMM
2019
Clinical Lymphoma, Myeloma & Leukemia
Meletios A. Dimopoulos
Katja Weisel
Philippe Moreau
Larry D. Anderson
Darrell White
Jesús F. San Miguel
Pieter Sonneveld
Monika Engelhardt
Matthew W. Jenner
Alessandro Corso
Jan Dürig
Michel Pavic
Morten Salomo
Eva Casalz
Ruiyun Jiang
Shankar Srinivasan
Tuong Vi Nguyen
Amine Bensmaine
Teresa Peluso
Paul G. Richardson
Show All
Source
Cite
Save
Citations (0)
1